tiprankstipranks
Trending News
More News >
Vaxil Bio Ltd (TSE:VXL)
:VXL
Canadian Market

Vaxil Bio (VXL) Cash flow

Compare
22 Followers

Vaxil Bio Cash Flow

TSE:VXL's free cash flow for Q2 2025 was C$-54.00K. For the 2025 fiscal year, TSE:VXL's free cash flow was decreased by C$321.00K and operating cash flow was C$-54.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -240.00KC$ -561.00KC$ -734.00KC$ -1.08MC$ -1.10M
Investing Cash Flow
C$ -250.00KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash Flow
C$ 0.00C$ 0.00C$ 0.00C$ 1.81MC$ 2.56M
End Cash Position
C$ 448.00KC$ 938.00KC$ 1.51MC$ 2.24MC$ 1.51M
Free Cash Flow
C$ -240.00KC$ -561.00KC$ -734.00KC$ -1.08MC$ -1.10M
Currency in CAD

Vaxil Bio Cash Flow